By Susan Buckles – Mayo Clinic
“The sky’s the limit,” “possibility” and “potential cure for disease” are aspirational ways Mayo Clinic physicians and scientists described regenerative medicine in a recent virtual presentation at the World Stem Cell Summit 2022. Mayo’s panel discussion showcased how it is advancing regenerative medicine through industry collaborations that accelerate scientific discoveries to early stage clinical trials.
Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Family Director of Mayo Clinic’s Center for Regenerative Medicine, moderated the “National Ecosystem Focused on Regenerative Biotherapeutics and the Importance of Collaborations” breakout session on June 9. Dr. Allickson also is the Otto Bremer Trust Director, Biomanufacturing and Product Development, Center for Regenerative Medicine.
“The first 10 years of regenerative medicine at Mayo Clinic was focused on education and building the infrastructure. We are now pivoting to lead development of cures in an innovative ecosystem,” says Dr. Allickson. “Our goal is to develop, manufacture and deliver novel products for unmet clinical needs of the patient.”
